Regencell Bioscience stock traded on the Nasdaq exchange, with ratings based on MarketBeat data, and Amundi opened a new position.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Regencell Bioscience stock traded on the Nasdaq exchange, with ratings based on MarketBeat data, and Amundi opened a new position.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regencell Bioscience
traditional Chinese herbal treatment company
- Regencell Bioscience Holdings Limited began trading on the electronic stock exchange on June 1, 2026, while facing a lawsuit invoking federal securities laws.
- Diageo is offering American-Made Foreign Liquor whiskies, RBB Bancorp serves Asian-American communities, and Regencell operates a Traditional Chinese medicine company.
-
Nasdaq
American fully electronic stock exchange
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale
Related events
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- Stock of Professional Diversity Network, Inc. traded on the Nasdaq exchange and was reported by MarketBeat.
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.
- Analyst reports published on MarketBeat regarding Tantech, a company whose stock trades on the Nasdaq stock exchange.
- Avax One Technology Ltd. stock is traded on the Nasdaq exchange, and MarketBeat reports analyst ratings for the company.